Myriad Genetics buy Piper Sandler
Start price
15.05.25
/
50%
€3.68
Target price
15.05.26
€8.04
Performance (%)
9.24%
Price
23.03.26
€3.90
Summary
This prediction is currently active. With a performance of 9.24%, the BUY prediction by Piper_Sandler for Myriad Genetics is trending in the right direction. This prediction currently runs until 15.05.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -1.015% | -1.015% |
| iShares Core DAX® | -3.509% | -8.747% |
| iShares Nasdaq 100 | -2.782% | -0.632% |
| iShares Nikkei 225® | -2.038% | -6.841% |
| iShares S&P 500 | -2.598% | -2.230% |
Comments by Piper_Sandler for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Piper Sandler from $12.50 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat

